21.06.2010 - An influential German drugs watchdog told health insurers to stop paying for GlaxoSmithKline's (GSK) Avandia, which could speed up a decline in sales of the controversial diabetes...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)